List of SBIR/STTR awards granted to Amelia Technologies LLC
Amelia Technologies LLCName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Amelia Technologies LLC in May, 2020 for $195,416.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41ES032435-01 | Phase I | 195,416 | May 1, 2020 | |||||||
A STTR Phase II contract was awarded to Amelia Technologies LLC in September, 2022 for $809,224.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42ES032435-02 | Phase II | 809,224 | September 20, 2022 | |||||||
A SBIR Phase II contract was awarded to Amelia Technologies LLC in May, 2018 for $1,495,902.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44ES026473-02 | Phase II | 1,495,902 | May 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Amelia Technologies LLC in September, 2020 for $274,324.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM139439-01 | Phase I | 274,324 | September 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Amelia Technologies LLC in February, 2021 for $250,051.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44ES032522-01 | Phase I | 250,051 | February 12, 2021 | |||||||
A SBIR Phase II contract was awarded to Amelia Technologies LLC in July, 2022 for $840,048.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44ES032522-02 | Phase II | 840,048 | July 21, 2022 | |||||||
A STTR Phase II contract was awarded to Amelia Technologies LLC in May, 2018 for $1,501,256.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42ES026908-02 | Phase II | 1,501,256 | May 15, 2018 |
